Search

Search Results

• Therapeutic gene transfer for rheumatoid arthritis

  M.C. Boissier, N. Bessis

  51-61

  https://doi.org/10.4081/reumatismo.2004.1s.51

  711

  PDF: 708

• TNF-α gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-α agents: preliminary results

  M. Fabris, E. Di Poi, S. Sacco, G. Damante, L. Sinigaglia, G. Ferraccioli

  19-26

  https://doi.org/10.4081/reumatismo.2002.19

  1291

  PDF: 764

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  https://doi.org/10.4081/reumatismo.2010.101

  1674

  PDF: 1018

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  https://doi.org/10.4081/reumatismo.2006.121

  1753

  PDF: 1717

• Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

  G. Ferraccioli

  46-50

  https://doi.org/10.4081/reumatismo.2004.1s.46

  696

  PDF: 692

• Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

  M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

  41-49

  https://doi.org/10.4081/reumatismo.2008.41

  1171

  PDF: 800
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1329

  3788

  PDF: 548

• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini

  107-117

  https://doi.org/10.4081/reumatismo.2009.107

  1910

  PDF: 1158

• Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity

  E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli

  16-21

  https://doi.org/10.4081/reumatismo.2005.16

  968

  PDF: 891
• 

  Treatment patterns of snti-TNF agents in Italy: an observational study

  L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

  18-28

  https://doi.org/10.4081/reumatismo.2011.18

  1298

  PDF: 965

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  https://doi.org/10.4081/reumatismo.2006.233

  1032

  PDF: 1001

• Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

  M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi

  65-68

  https://doi.org/10.4081/reumatismo.2009.65

  1348

  PDF: 1050

• Disability and quality of life of patients with rheumatoid arthritis: assessment and perspectives

  F. Salaffi, A. Stancati

  87-106

  https://doi.org/10.4081/reumatismo.2004.1s.87

  1304

  PDF: 3388
• 

  Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

  G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone

  24-30

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1154

  1582

  PDF: 1103

• short history of anti-rheumatic therapy. IV. Corticosteroids

  G. Pasero, P. Marson

  292-299

  https://doi.org/10.4081/reumatismo.2010.292

  1773

  PDF: 1919

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  https://doi.org/10.4081/reumatismo.2007.235

  1504

  PDF: 972
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1243

  1543

  PDF: 739

• The rehabilitative approach in rheumatoid arthritis

  G. Arioli, S. Maddali Bongi, N. Pappone

  242-248

  https://doi.org/10.4081/reumatismo.2008.242

  1751

  PDF: 1978

• Correlation between radiographic, echographic and MRI changes and rheumatoid arthritis progression

  M.A. Cimmino, M. Parodi, E. Silvestri, G. Garlaschi

  28-40

  https://doi.org/10.4081/reumatismo.2004.1s.28

  991

  PDF: 2942

• Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden

  A. Ciocci, L. Buratti, G. Coari, M. Di Franco, A.M. Iagnocco, M.T. Mauceri, A. Serio

  215-222

  https://doi.org/10.4081/reumatismo.2001.215

  1094

  PDF: 743

• Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania’s study

  D. Marotto, M.E. Nieddu, A. Cossu, A. Carcassi

  273-276

  https://doi.org/10.4081/reumatismo.2005.273

  791

  PDF: 2288

• Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations

  D. Biscontini, E. Bartoloni Bocci, R. Gerli

  48-53

  https://doi.org/10.4081/reumatismo.2009.48

  1431

  PDF: 992

• Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients pheripheral blood mononuclear cells stimulated with lipopolysaccharide

  M. Fabris, B. Tolusso, E. Gremese, P. Tomietto, G. Ferraccioli

  94-103

  https://doi.org/10.4081/reumatismo.2004.94

  1353

  PDF: 930
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.922

  4555

  PDF: 3056

• Stress response system and personality in rheumatoid arthritis patients

  C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

  204-209

  https://doi.org/10.4081/reumatismo.2001.204

  1372

  PDF: 889

• Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)

  V. Bruzzese, J. Pepe

  306-308

  https://doi.org/10.4081/reumatismo.2009.306

  969

  PDF: 786

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  https://doi.org/10.4081/reumatismo.2005.267

  1062

  PDF: 1688

• Role of cell migration in the pathogenesis of rheumatoid arthritis: in vivo studies in SCID mice transplanted with human synovial membrane

  F. Ingegnoli, M. Blades, A. Manzo, S. Wahid, M. Perretti, G. Panay, C. Pitzalis

  128-132

  https://doi.org/10.4081/reumatismo.2002.128

  819

  PDF: 845

• Atherosclerosis in rheumatoid arthtritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness

  M. Carotti, F. Salaffi, M. Mangiacotti, A. Cerioni, G.M. Giuseppetti, W. Grassi

  38-49

  https://doi.org/10.4081/reumatismo.2007.38

  2110

  PDF: 1111

• Infliximab treatment in a case of rheumatoid scleromalacia perforans

  R. Herrera-Esparza, E. Avalos-Diaz

  212-215

  https://doi.org/10.4081/reumatismo.2009.212

  1205

  PDF: 983

• Recurrent acute idiopathic pericarditis: rheumatologic therapy, autoantibodies and long term outcome

  G. Brambilla, A. Brucato, Y. Adler, M. Bosetti, P. Coppini, A. Caforio, D. Spodick, B. Canesi

  25-31

  https://doi.org/10.4081/reumatismo.2007.25

  1239

  PDF: 1144

• Hidden bone erosions

  E. Filippucci, A. Farina, F. Salaffi, W. Grassi

  52-55

  https://doi.org/10.4081/reumatismo.2003.52

  1082

  PDF: 4784

• Synoviocyte cultures from synovial fluid

  A. Scanu, F. Oliviero, L. Braghetto, R. Ramonda, R. Luisetto, F. Calabrese, A. Pozzuoli, L. Punzi

  66-70

  https://doi.org/10.4081/reumatismo.2007.66

  1637

  PDF: 1060

• Metabolic syndrome in inflammatory rheumatic diseases

  D. Malesci, G. Valentini, G. La Montagna

  169-176

  https://doi.org/10.4081/reumatismo.2006.169

  1725

  PDF: 3879

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  132-139

  https://doi.org/10.4081/reumatismo.2009.132

  1917

  PDF: 1140

• The arthropathy of systemic sclerosis

  D. Malesci, G. La Montagna, G. Valentini

  232-237

  https://doi.org/10.4081/reumatismo.2005.232

  29687

  PDF: 2094
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1602

  1828

  PDF: 454
• 

  Translation and cross-cultural adaptation into Italian of the self-administered FLARE-RA questionnaire for rheumatoid arthritis

  N. Ughi, T. Schioppo, I. Scotti, V. Merlino, A. Murgo, O. De Lucia, B. Fautrel, F. Guillemin, R. Christensen, F. Ingegnoli

  21-30

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1230

  1188

  PDF: 754
• 

  Histopathology of the skin in rheumatic diseases

  M.S. Chimenti, A. Di Stefani, P. Conigliaro, A. Saggini, S. Urbani, A. Giunta, M. Esposito, L. Bianchi, K. Peris, R. Perricone

  187-198

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1049

  3107

  PDF: 1890

• Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies

  A. Spadaro, M.L. Sorgi, R. Scrivo, A. Picarelli, M. Di Tola, L. Sabbatella, E. Taccari

  344-350

  https://doi.org/10.4081/reumatismo.2002.344

  1092

  PDF: 1663

• Magnetic resonance imaging of the joints: a revolution for the practicing rheumatologist

  M.A. Cimmino

  239-241

  https://doi.org/10.4081/reumatismo.2008.239

  1013

  PDF: 674

• Accuracy and standardization of diagnostic methods for the detection of antibodies to citrullinated peptides

  N. Bizzaro, M. Tampoia

  222-228

  https://doi.org/10.4081/reumatismo.2009.222

  1078

  PDF: 862

• Role of chemokines in the pathogenesis of rheumatoid synovitis

  F. Ingegnoli, A. Manzo, F. Fantini, R. Caporali, C. Montecucco, N. Pipitone, C. Pitzalis

  12-18

  https://doi.org/10.4081/reumatismo.2002.12

  785

  PDF: 817

• Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis

  A. Spadaro, V. Riccieri, C. Alessandri, R. Scrivo, G. Valesini

  116-120

  https://doi.org/10.4081/reumatismo.2006.116

  1212

  PDF: 1192
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1289

  1634

  PDF: 1013

• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

  M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

  253-258

  https://doi.org/10.4081/reumatismo.2010.253

  2080

  PDF: 836

• The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

  P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo

  109-113

  https://doi.org/10.4081/reumatismo.2005.109

  1017

  PDF: 3805
• 

  Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?

  K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid

  203-208

  28-01-2020

  https://doi.org/10.4081/reumatismo.2019.1222

  1892

  PDF: 858

• Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?

  F. Atzeni, P. Sarzi-Puttini

  1-3

  https://doi.org/10.4081/reumatismo.2009.1

  1512

  PDF: 715
• 

  Can restless legs be a sign of something else? A case report of spondyloarthritis presenting with restless legs syndrome and a review of the literature

  E. Yılmaz

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1557

  2061

  PDF: 604